[Synthesis of virus-specific RNA in influenza virus-infected cells in the presence of bonafton].
S F
SF
Gerasina
V R
VR
Farashian
N I
NI
Fadeeva
G N
GN
Pershin
V M
VM
Zhdanov
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002642:Chick Embryo; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005814:Genes, Viral / Q000187:drug effects; D009980:Influenza A virus / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D009285:Naphthoquinones / Q000627:therapeutic use*; D009976:Orthomyxoviridae Infections / Q000188:drug therapy* / Q000382:microbiology; D012313:RNA / Q000037:antagonists & inhibitors; D018075:RNA, Complementary; D012335:RNA, Ribosomal / Q000037:antagonists & inhibitors; D012367:RNA, Viral / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D014158:Transcription, Genetic / Q000187:drug effects; D014776:Virus Cultivation; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D009285:Naphthoquinones; D018075:RNA, Complementary; D012335:RNA, Ribosomal; D012367:RNA, Viral; D012313:RNA; C011180:bonafton
Sintez virusspetsificheskikh RNK v infitsirovannykh virusom grippa kletkakh v prisutstvii bonaftona.